What is Campylobacteriosis Market Scope?
Campylobacteriosis is caused by a bacteria called Campylobacter jejuni, which is found worldwide in the intestinal tracts of animals. The bacteria are spiral-shaped and can cause disease in animals and humans. Most cases of campylobacteriosis are associated with handling or eating raw or undercooked poultry meat. Campylobacteriosis causes gastrointestinal symptoms, such as diarrhea, cramping, abdominal pain, and fever in domestic animals and humans. Young animals and humans are the most severely affected. This has projected the growth of the global campylobacteriosis treatment market in the forecast period.
The Campylobacteriosis market study is being classified, by Application (Hospitals, Clinics, Private Laboratories, Independent Physician Chambers and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Campylobacteriosis market throughout the predicted period.
Meridian Bioscience, Inc. (United States), Becton, Dickinson and Company (United States), Siemens Healthineers (Germany), BIOTECON Diagnostics (Germany), Agilent Technologies (United States), Thermo Fisher Scientific (United States), Alere Inc. (United States), QIAGEN (Germany), Roche Molecular Systems, Inc. (United States), Lonza (Switzerland), ZeptoMetrix (United States) and Sequenom (United States) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Campylobacteriosis market by Type, Application and Region.
On the basis of geography, the market of Campylobacteriosis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 23rd January 2018, TECHLAB Inc. has announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK and the CAMPYLOBACTER CHEK tests. Both are intended to aid the diagnosis of campylobacteriosis, one of the most common causes of diarrheal illness in the United States.
WHO is working towards the strengthening of food safety systems in an increasingly globalized world. Setting international food safety standards, enhancing disease surveillance, educating consumers, and training food handlers in safe food handling are amongst the most critical interventions in the prevention of foodborne illnesses.
Influencing Market Trend
- Rising Clinical Research Studies for Campylobacteriosis Diagnosis
- Increasing Number of Humans, which Affected with Campylobacteriosis Infection
- Growing Infection in Animals across the Worldwide
- Increasing Research and Development Activities Focused on Campylobacteriosis
- Rising Purchasing Power of Developing Countries
- Lack of Awareness About Campylobacteriosis Infection
- Strict Government Regulations
Key Target Audience
Campylobacteriosis Drugs Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.